Centre Hospitalier de la Croix Rousse

Lyon, Rhone 69317

0 studies enrolling now · 4 studies all time

What they study most

Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Diabetic Macular Edema, First Line Non-Small Cell Lung Cancer, Hemi-retinal Vein Occlusion, Hepatitis Delta Virus, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion, Solid Tumors

Studies at this site

• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors — Completed
• Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a — Completed